Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Preventive Maintenance of Clinical Equipment – V 2.0

Posted on By

BA-BE Studies: SOP for Preventive Maintenance of Clinical Equipment – V 2.0

Standard Operating Procedure for Preventive Maintenance of Clinical Equipment in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/116/2025
Supersedes SOP/BA-BE/116/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define a standardized procedure for the scheduling, execution, and documentation of preventive maintenance for clinical equipment used in the conduct of Bioavailability/Bioequivalence (BA/BE) studies to ensure operational readiness and compliance with regulatory standards.

2. Scope

This SOP is applicable to all clinical equipment including but not limited to ECG machines, centrifuges, freezers, refrigerators, blood pressure monitors, weighing balances, and

emergency resuscitation kits used during BA/BE trials.

3. Responsibilities

  • Maintenance Officer: Schedules preventive maintenance activities and performs internal checks or coordinates with vendors.
  • QA Officer: Verifies maintenance logs and ensures regulatory compliance through periodic audits.
  • Clinical Facility Coordinator: Ensures equipment is available, cleaned, and ready before scheduled maintenance.
  • Vendor Technician: Performs calibration and maintenance as per manufacturer’s standards and signs service report.
See also  BA-BE Studies: SOP for Emergency Exit and Fire Drill Plan at Clinical Site - V 2.0

4. Accountability

The Head of Clinical Operations is accountable for ensuring that all clinical equipment is properly maintained and documented to prevent study disruptions and protect subject safety.

5. Procedure

5.1 Equipment Inventory and Maintenance Planning

  1. Maintain a master list of clinical equipment with:
    • Equipment name
    • Model number
    • Location
    • Serial number
  2. Develop a preventive maintenance schedule based on:
    • Manufacturer’s recommendation
    • Usage frequency
    • Criticality to study operations
  3. Document the plan using Annexure-1: Annual Maintenance Schedule.

5.2 Execution of Maintenance Activities

  1. Initiate maintenance as per planned schedule or before study initiation.
  2. Ensure the following steps are covered:
    • Visual inspection
    • Calibration (where applicable)
    • Functional verification
    • Cleaning and lubrication (as required)
  3. Complete Annexure-2: Preventive Maintenance Checklist for each equipment.
See also  BA-BE Studies: SOP for Handling Cold Chain Breaches During Sample Storage - V 2.0

5.3 External Vendor Engagement

  1. Select vendors based on:
    • Experience and certification
    • Calibration traceability to national/international standards
  2. Obtain calibration certificates and attach them to Annexure-3: Equipment Service Record.

5.4 Deviation Handling and Repairs

  1. If equipment is found out of specification:
    • Tag as “OUT OF ORDER” and remove from service
    • Document using Annexure-4: Equipment Breakdown Log
    • Initiate corrective action or replacement immediately

5.5 Post-Maintenance Documentation

  1. Attach:
    • Checklists
    • Service reports
    • Calibration certificates
  2. File documents in the Equipment Qualification & Maintenance Folder.
  3. QA shall review and sign off post-maintenance records monthly.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • QA: Quality Assurance
  • OOS: Out of Specification
  • SOP: Standard Operating Procedure

7. Documents

  1. Annual Maintenance Schedule – Annexure-1
  2. Preventive Maintenance Checklist – Annexure-2
  3. Equipment Service Record – Annexure-3
  4. Equipment Breakdown Log – Annexure-4

8. References

  • ICH E6(R2) – Good Clinical Practice
  • WHO Technical Report Series on Clinical Site Requirements
  • Manufacturer Equipment Manuals
See also  BA-BE Studies: SOP for Monitoring Vital Signs During Clinical Phase - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Annual Maintenance Schedule

Equipment Name Location Frequency Next Due Date
ECG Machine Room 101 Quarterly 15/07/2025

Annexure-2: Preventive Maintenance Checklist

Equipment Activity Performed By Date Remarks
BP Monitor Calibration Rajesh Kumar 15/04/2025 OK

Annexure-3: Equipment Service Record

Equipment Service Date Vendor Certificate Attached
Centrifuge 12/04/2025 ABC Biomedical Yes

Annexure-4: Equipment Breakdown Log

Date Equipment Issue Status Corrective Action
10/04/2025 Refrigerator Not cooling Repaired Compressor replaced

Revision History:

Revision Date Revision No. Details Reason Approved By
12/01/2022 1.0 Initial Release GCP Requirement QA Head
17/04/2025 2.0 Added annexures and external vendor engagement criteria Annual SOP Review QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: API Manufacturing: SOP for Sampling of Toxic and Potent Compounds – V 2.0
Next Post: Biosimilars: SOP for Deviation Handling During Clone Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version